---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T14:11:48.759975'
end_time: '2025-12-27T14:19:27.817105'
duration_seconds: 459.06
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: RAB7A
  gene_symbol: RAB7A
  uniprot_accession: P51149
  protein_description: 'RecName: Full=Ras-related protein Rab-7a {ECO:0000305}; EC=3.6.5.2
    {ECO:0000269|PubMed:20028791};'
  gene_info: Name=RAB7A {ECO:0000312|HGNC:HGNC:9788}; Synonyms=RAB7;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the small GTPase superfamily. Rab family.
  protein_domains: P-loop_NTPase. (IPR027417); Small_GTP-bd. (IPR005225); Small_GTPase.
    (IPR001806); Ras (PF00071)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 13
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P51149
- **Protein Description:** RecName: Full=Ras-related protein Rab-7a {ECO:0000305}; EC=3.6.5.2 {ECO:0000269|PubMed:20028791};
- **Gene Information:** Name=RAB7A {ECO:0000312|HGNC:HGNC:9788}; Synonyms=RAB7;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Ras (PF00071)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB7A" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB7A' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB7A** (gene ID: RAB7A, UniProt: P51149) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P51149
- **Protein Description:** RecName: Full=Ras-related protein Rab-7a {ECO:0000305}; EC=3.6.5.2 {ECO:0000269|PubMed:20028791};
- **Gene Information:** Name=RAB7A {ECO:0000312|HGNC:HGNC:9788}; Synonyms=RAB7;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Ras (PF00071)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB7A" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB7A' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB7A** (gene ID: RAB7A, UniProt: P51149) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan status: We verified gene identity; gathered recent primary/review evidence with emphasis on 2023–2024; synthesized molecular function, regulators, localization, pathways, effectors; summarized disease relevance and applications; extracted quantitative/mechanistic details where supported; and created a summary artifact.

Gene/protein verification and identity
- Target: RAB7A, Ras-related protein Rab-7a, Homo sapiens. Member of the small GTPase Rab family with P-loop NTPase/small GTP-binding fold. Functions as a membrane trafficking switch on late endosomes/lysosomes/autophagosomes. This identity and family context are consistent with recent mechanistic studies of Rab7 activation during Rab5→Rab7 endosome maturation (Mon1–Ccz1 GEF) (Borchers et al., PNAS, 2023, published Jul 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2). Rab7A’s canonical cycle and localization to late endosomes/lysosomes are reiterated in contemporary sources (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66), and in a 2023 neuron-focused review (Mulligan & Winckler, Biomolecules, Sep 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).

Molecular function and enzymatic cycle (EC 3.6.5.2)
- Biochemical role: Small GTPase molecular switch. GDP-bound Rab7A is cytosolic/inactive; GTP-bound Rab7A is membrane-associated/active and recruits effectors to control trafficking, fusion, and motility of late endosomes/lysosomes and autophagosomes (Valencia, 2024; review context; unknown journal) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54).
- GEF-mediated activation: The Mon1–Ccz1 complex is the principal Rab7 GEF on endosomal membranes; recruitment and activity are stimulated by Rab5 to drive the Rab5→Rab7 conversion central to endosomal maturation. 2023 structural/biochemical work identified (i) an autoinhibitory, intrinsically disordered Mon1 N-terminus that limits Rab5-dependent GEF activity and (ii) a conserved Rab5-binding site on Mon1 essential for membrane GEF function and maturation in vivo (Borchers et al., PNAS, 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- Accessory subunits: C5orf51 and the trimeric MCC (Mon1–Ccz1–C18orf8/RMC1) module stabilize Rab7 activation and positioning of the GEF; C5orf51 binds GDP-locked RAB7A and interacts with MON1/CCZ1, supporting Rab7 localization and stability (Valencia, 2024; review synopsis) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54).
- GAP-mediated inactivation: TBC-domain GAPs such as TBC1D15 and TBC1D5 stimulate Rab7 GTP hydrolysis and membrane release; TBC1D5 links to retromer and autophagy machinery, whereas TBC1D15 associates with mitochondria via Fis1, influencing mitophagy and autophagosome size (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 62-66).
- Post-translational regulation: Rab7A is subject to ubiquitylation and phosphorylation (e.g., S72; Y183) and lipidation such as palmitoylation; these PTMs modulate effector interactions and trafficking outputs (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54).

Subcellular localization and core cellular roles
- Localization: Late endosomes/multivesicular bodies and lysosomes are primary sites; Rab7A also acts on autophagosomes and can be recruited to damaged mitochondria during Parkin/PINK1-dependent mitophagy (Cai et al., Autophagy, Jun 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3). Contemporary reviews reiterate LE/lysosomal Rab7A localization and functions (Wong, 2024) (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66).
- Endosome maturation: Rab7A is activated by Mon1–Ccz1 downstream of Rab5, marking the transition from early to late endosomes and enabling recruitment of late endosomal effectors, acidification, and maturation (Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- Autophagosome–lysosome fusion and autophagic flux: Rab7A recruits fusion tethers and effectors to promote autophagosome maturation and autolysosome formation; NRBF2 functions as a Rab7 effector that sustains Mon1–Ccz1 GEF activity and thereby Rab7-GTP generation on maturing autophagic compartments (Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3). Recent mechanistic summaries emphasize HOPS as a Rab7 effector tether for LE/lysosome and autophagosome fusion (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Acidification coupling and pH sensing: Acute collapse of late endosome pH triggers rapid Rab7 hyperactivation via increased assembly of the V-ATPase V1G1 subunit and stabilization of Rab7-GTP through RILP, with functional consequences on CI-M6PR tubulation/retrieval (Mulligan et al., J Cell Sci, May 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- Mitophagy: Rab7A participates in Parkin/PINK1-dependent mitophagy, including recruitment to damaged mitochondria and coordination with Mon1–Ccz1 and PI3KC3 complexes; NRBF2 maintains the Mon1–Ccz1 GEF–Rab7 axis necessary for autophagosome maturation on APP-containing and autophagic cargo vesicles (Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3).
- Lipid droplet turnover (lipophagy/microlipophagy): Rab7A is implicated in lipid droplet catabolism via late endosome/lysosome pathways in both macrolipophagy and contact/fusion processes; mechanistic overviews place Rab7A at the autophagic–endo-lysosomal interface controlling cargo delivery and degradation (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66).

Principal effectors and pathway modules
- Motor recruitment and positioning: RILP is a canonical Rab7 effector that binds dynein–dynactin to drive minus-end transport and perinuclear late endosome/lysosome positioning; RILP also links to the V-ATPase (V1G1) during pH-triggered responses (Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4). Reviews also place RILP and FYCO1 as opposing directional adaptors on Rab7-positive organelles (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Tethering and fusion: HOPS complex functions as a Rab7 effector to tether late endosomes and autophagosomes to lysosomes prior to SNARE-mediated fusion (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Cargo recycling and maturation: Retromer (VPS35/VPS26/VPS29) associates with Rab7-positive endosomes to mediate retrograde transport (e.g., CI-M6PR retrieval) and regulate endosome maturation; dysfunction of Rab7–retromer coupling perturbs hydrolase sorting (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationby pages 51-54).
- Contact site and lipid/cholesterol regulation: ORP1L (oxysterol-binding protein-related protein) and PLEKHM1 act as Rab7 effectors coordinating contacts and tethering/fusion of late endosome/lysosome compartments; PLEKHM1 supports HOPS recruitment and autophagosome–lysosome fusion (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationby pages 51-54).
- Autophagy maturation scaffold: NRBF2 directly binds Rab7 and supports CCZ1–MON1A GEF function and PI3KC3 activity for autophagosome maturation (Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3).

Recent (2023–2024) developments
- Mon1–Ccz1 GEF regulation: Comprehensive 2023 PNAS study demonstrated autoinhibitory control within Mon1 and a critical Rab5-binding site enabling Rab5-stimulated GEF activity on membranes, thereby directly linking Rab5 presence to Rab7 activation and endosome maturation (Borchers et al., PNAS, Jul 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- pH-coupled Rab7 activation: Neutralization of late endosomal pH rapidly hyperactivates Rab7 via V-ATPase V1G1 assembly and RILP, disrupting tubulation and CI-M6PR recycling (Mulligan et al., J Cell Sci, May 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- Neuronal trafficking and CMT2B insights: A 2023 review synthesizes evidence that CMT2B-linked RAB7A alleles show increased nucleotide exchange and elevated GTP-bound state (“rapid cycling”), altered effector balance, and defects in endosomal receptor (e.g., TrkA) trafficking in neurons, consistent with disrupted trophic signaling; the review summarizes model and patient-cell findings linking altered autophagy and mitochondrial dynamics (Mulligan & Winckler, Biomolecules, Sep 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).
- Autophagosome maturation checkpoint: NRBF2 as a Rab7 effector that sustains Mon1–Ccz1 GEF and PI3KC3 activities, coupling autophagosome maturation with Rab7 activation on autolysosomal compartments; this mechanistic link informs neurodegeneration and APP-CTF turnover (Cai et al., Autophagy, 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3).

Disease relevance, applications, and real-world implementations
- CMT2B neuropathy: Dominant missense RAB7A alleles in CMT2B alter GTPase cycling and endosomal trafficking in neurons, with consensus that mutants exhibit increased activation/“rapid cycling,” perturbing neurotrophin receptor trafficking, autophagosome dynamics, and mitochondrial homeostasis; these mechanisms suggest targets along the Rab7 activation cycle and effector interactions for therapeutic exploration (Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).
- Cancer and signaling: Rab7A–retromer–lysosome axis controls receptor downregulation (e.g., EGFR) and proteostasis; Rab7A PTMs (e.g., Y183, S72) and effector networks influence degradative flux and endosomal signaling crosstalk, with implications for oncogenic pathways and lysosomal stress responses (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54). V-ATPase–RILP–Rab7A coupling to luminal pH provides a direct mechanistic entrypoint for modulating endolysosomal signaling in disease (Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- Infection/host–pathogen interactions: Contemporary overviews reiterate that Rab7A coordinates degradative endolysosomal traffic and autophagosome maturation, pathways often manipulated by pathogens; control nodes include the Mon1–Ccz1 GEF, HOPS tether, and Rab7 GAPs (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 62-66).

Selected quantitative/mechanistic data
- Endosome maturation switch: Loss of Mon1 Rab5-binding or GEF autoinhibition control impairs Rab7 activation on membranes and causes in vivo growth defects and shifts in endosomal identities in Drosophila/yeast models, supporting the causal mechanism of Rab5-stimulated Mon1–Ccz1 GEF activity (Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- pH-triggered Rab7 hyperactivation: Acute LE pH neutralization phenocopies Rab7 hyperactive states with defects in CI-M6PR recycling/tubulation; mechanistically, increased V1G1 assembly stabilizes Rab7-GTP through RILP (Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- CMT2B mutant behavior: Integrative 2023 review concludes CMT2B variants elevate GTP-bound fractions and alter GTPase cycling independent of GEF, with downstream autophagy/mitochondrial dynamics changes in neuronal models and patient-derived cells (Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).

Key regulators/cargo modules (concise)
- GEFs: Mon1–Ccz1 (Rab5-stimulated; autoinhibited Mon1 N-terminus; essential Rab5-binding site) (Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- GAPs: TBC1D5 (retromer-linked), TBC1D15 (mitochondria/mitophagy), and other TBC-domain GAPs regulating late endosome/autophagy dynamics (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Effectors: RILP (dynein/dynactin; V-ATPase V1G1 linkage), HOPS (tethering/fusion), retromer/VPS35 (retrograde sorting), ORP1L and PLEKHM1 (contact and tether/fusion coordination), NRBF2 (Rab7 effector sustaining Mon1–Ccz1/PI3KC3) (Mulligan et al., 2024; Cai et al., 2021; Valencia, 2024) (mulligan2024collapseoflate pages 1-4, cai2021nrbf2isa pages 1-3, valencia2024rab7palmitoylationby pages 51-54).

Embedded summary table
| Feature | Summary | Key citations |
|---|---|---|
| Identity verification | RAB7A (UniProt P51149); organism: Homo sapiens; small GTPase, Rab family; domains: P-loop NTPase / small GTP-binding (Ras) fold. | Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120 (borchers2023regulatorysitesin pages 1-2) |
| Molecular function | Small GTPase (EC 3.6.5.2): cycles between GDP- (inactive) and GTP- (active) bound states to recruit effectors; GTP hydrolysis drives state change. | Valencia 2024 (reviewed regulatory PTMs and cycle) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54) |
| Primary regulators | GEFs: Mon1–Ccz1 (with C18orf8/RMC1 accessory subunit) activate Rab7; GAPs: TBC1D15, TBC1D5 (and related TBC proteins) inactivate Rab7. | Mon1–Ccz1 regulatory/GEF work: Borchers et al., 2023; Mon1–Ccz1 functional context (borchers2023regulatorysitesin pages 1-2); GAP roles (reviews) (wong2024ampkregulatesthe pages 62-66) |
| Key effectors | RILP (dynein recruitment), HOPS (tethering/fusion), retromer/VPS35 (retrograde sorting), ORP1L, PLEKHM1, NRBF2 (autophagosome maturation effector). | NRBF2 functional link: Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623 (cai2021nrbf2isa pages 1-3); effector summaries (valencia2024rab7palmitoylationby pages 51-54) |
| Principal localizations | Late endosomes, multivesicular bodies, lysosomes, autophagosomes; recruited transiently to damaged mitochondria during mitophagy; participates in ER–mitochondria–lysosome membrane contact sites. | Autophagy/membrane sites & Rab7 roles: Cai et al., 2021 (cai2021nrbf2isa pages 1-3); endosomal pH/Rab7 coupling: Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765 (mulligan2024collapseoflate pages 1-4) |
| Core pathways | Endosome maturation (Rab5 → Rab7 conversion); autophagosome–lysosome fusion and autophagic flux; mitophagy (Parkin/PINK1/TBK1-linked recruitment); lipophagy/microlipophagy (LD turnover). | Mon1–Ccz1 Rab conversion: Borchers et al., 2023 (borchers2023regulatorysitesin pages 1-2); mitophagy/autophagy links: Cai et al., 2021 (cai2021nrbf2isa pages 1-3); pathway reviews (wong2024ampkregulatesthe pages 62-66) |
| Selected 2023–2024 advances | 1) Mon1–Ccz1 autoinhibition and conserved Rab5-binding site that controls Rab5→Rab7 conversion (Borchers 2023). 2) LE pH neutralization drives rapid Rab7 hyper-activation via V-ATPase V1G1 assembly and RILP stabilization (Mulligan 2024). 3) NRBF2 identified as a Rab7 effector that supports Mon1–Ccz1 GEF activity and autophagosome maturation (Cai 2021; mechanistic relevance emphasized in recent work). 4) Mechanistic/neuronal studies clarify CMT2B mutant behavior (constitutively higher GTP-bound fractions and disrupted autophagy/mitochondrial dynamics). | Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120 (borchers2023regulatorysitesin pages 1-2); Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765 (mulligan2024collapseoflate pages 1-4); Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623 (cai2021nrbf2isa pages 1-3); Mulligan & Winckler 2023 (CMT2B review) https://doi.org/10.3390/biom13091399 (mulligan2023regulationofendosomal pages 2-4) |
| Disease notes / applications | CMT2B: dominant RAB7A missense mutations (e.g., V162M, K126R, others) show increased nucleotide exchange / higher GTP-bound fraction and impaired autophagic flux and mitochondrial defects in patient cells and models; implications in neurodegeneration. Emerging roles in cancer and infection via dysregulated endolysosomal trafficking and signaling. | CMT2B functional data and review: Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399 (mulligan2023regulationofendosomal pages 2-4); mitochondrial/autophagy links: Gu et al., 2022 (discussed in reviews captured) (mulligan2023regulationofendosomal pages 2-4, cai2021nrbf2isa pages 1-3) |


*Table: Compact reference table summarizing identity, function, regulators, effectors, localization, key pathways, recent advances (2023–2024), and disease notes for human RAB7A (UniProt P51149), with primary citations to the collected evidence.*

Expert perspectives and consensus
- Converging data place Rab7A as the central organizer of the degradative endolysosomal/autophagic pathway in mammalian cells, with GEFs (Mon1–Ccz1–C18orf8/RMC1), GAPs (TBC1D15/D5), and effectors (RILP/HOPS/retromer/PLEKHM1/NRBF2) forming a modular network tuned by Rab5 input and luminal pH. Recent work refined how Rab5 presence licenses Mon1–Ccz1 activity and revealed a V-ATPase–RILP axis that ties luminal pH to Rab7 activation, providing concrete mechanisms for trafficking defects observed across neurodegeneration, infection, and cancer models (Borchers et al., 2023; Mulligan et al., 2024) (borchers2023regulatorysitesin pages 1-2, mulligan2024collapseoflate pages 1-4).

Limitations and open questions
- While neuronal disease mechanisms implicate elevated Rab7-GTP and altered effector balance in CMT2B, precise, quantitative, variant-specific kinetics and structural determinants in human cells remain incompletely defined, and will benefit from systematic, allele-by-allele biochemical and proximity-mapping studies integrated with live-cell trafficking metrics (Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).

References (URLs and dates)
- Borchers AC et al. Regulatory sites in the Mon1–Ccz1 complex control Rab5 to Rab7 transition and endosome maturation. PNAS. Jul 2023. https://doi.org/10.1073/pnas.2303750120 (borchers2023regulatorysitesin pages 1-2)
- Mulligan RJ et al. Collapse of late endosomal pH elicits a rapid Rab7 response via the V-ATPase and RILP. Journal of Cell Science. May 2024. https://doi.org/10.1242/jcs.261765 (mulligan2024collapseoflate pages 1-4)
- Mulligan RJ, Winckler B. Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from CMT2B Disease. Biomolecules. Sep 2023. https://doi.org/10.3390/biom13091399 (mulligan2023regulationofendosomal pages 2-4)
- Cai C-Z et al. NRBF2 is a RAB7 effector required for autophagosome maturation and mediates the association of APP-CTFs with active RAB7 for degradation. Autophagy. Jun 2021. https://doi.org/10.1080/15548627.2020.1760623 (cai2021nrbf2isa pages 1-3)
- Valencia LDT. Rab7 palmitoylation by zdhhc11 and phosphorylation by nek7 as modulators of endo-lysosomal trafficking in batten disease. 2024. (review-style excerpt). (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54)
- Wong C. AMPK regulates the release of exosomal miRNAs… 2024. (sections summarizing Rab7 regulation and effectors). (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66)


References

1. (borchers2023regulatorysitesin pages 1-2): Ann-Christin Borchers, Maren Janz, Jan-Hannes Schäfer, Arne Moeller, Daniel Kümmel, Achim Paululat, Christian Ungermann, and Lars Langemeyer. Regulatory sites in the mon1–ccz1 complex control rab5 to rab7 transition and endosome maturation. Proceedings of the National Academy of Sciences, Jul 2023. URL: https://doi.org/10.1073/pnas.2303750120, doi:10.1073/pnas.2303750120. This article has 23 citations and is from a highest quality peer-reviewed journal.

2. (wong2024ampkregulatesthe pages 58-62): C Wong. Ampk regulates the release of exosomal mirnas to facilitate neuron-germ line communication during the dauer stage. Unknown journal, 2024.

3. (wong2024ampkregulatesthe pages 62-66): C Wong. Ampk regulates the release of exosomal mirnas to facilitate neuron-germ line communication during the dauer stage. Unknown journal, 2024.

4. (mulligan2023regulationofendosomal pages 2-4): Ryan J. Mulligan and Bettina Winckler. Regulation of endosomal trafficking by rab7 and its effectors in neurons: clues from charcot–marie–tooth 2b disease. Biomolecules, 13:1399, Sep 2023. URL: https://doi.org/10.3390/biom13091399, doi:10.3390/biom13091399. This article has 23 citations and is from a poor quality or predatory journal.

5. (valencia2024rab7palmitoylationbya pages 51-54): LD Tejeda Valencia. Rab7 palmitoylation by zdhhc11 and phosphorylation by nek7 as modulators of endo-lysosomal trafficking in batten disease. Unknown journal, 2024.

6. (valencia2024rab7palmitoylationby pages 51-54): LD Tejeda Valencia. Rab7 palmitoylation by zdhhc11 and phosphorylation by nek7 as modulators of endo-lysosomal trafficking in batten disease. Unknown journal, 2024.

7. (cai2021nrbf2isa pages 1-3): Cui-Zan Cai, Chuanbin Yang, Xu-Xu Zhuang, Ning-Ning Yuan, Ming-Yue Wu, Jie-Qiong Tan, Ju-Xian Song, King-Ho Cheung, Huanxing Su, Yi-Tao Wang, Bei-Sha Tang, Christian Behrends, Siva Sundara Kumar Durairajan, Zhenyu Yue, Min Li, and Jia-Hong Lu. Nrbf2 is a rab7 effector required for autophagosome maturation and mediates the association of app-ctfs with active form of rab7 for degradation. Autophagy, 17:1112-1130, Jun 2021. URL: https://doi.org/10.1080/15548627.2020.1760623, doi:10.1080/15548627.2020.1760623. This article has 54 citations and is from a domain leading peer-reviewed journal.

8. (mulligan2024collapseoflate pages 1-4): Ryan J. Mulligan, Magdalena M. Magaj, Laura Digilio, Stefanie Redemann, Chan Choo Yap, and Bettina Winckler. Collapse of late endosomal ph elicits a rapid rab7 response via the v-atpase and rilp. Journal of Cell Science, May 2024. URL: https://doi.org/10.1242/jcs.261765, doi:10.1242/jcs.261765. This article has 13 citations and is from a domain leading peer-reviewed journal.

## Citations

1. borchers2023regulatorysitesin pages 1-2
2. mulligan2023regulationofendosomal pages 2-4
3. wong2024ampkregulatesthe pages 62-66
4. mulligan2024collapseoflate pages 1-4
5. wong2024ampkregulatesthe pages 58-62
6. https://doi.org/10.1073/pnas.2303750120
7. https://doi.org/10.3390/biom13091399
8. https://doi.org/10.1080/15548627.2020.1760623
9. https://doi.org/10.1242/jcs.261765
10. https://doi.org/10.1073/pnas.2303750120,
11. https://doi.org/10.3390/biom13091399,
12. https://doi.org/10.1080/15548627.2020.1760623,
13. https://doi.org/10.1242/jcs.261765,